SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014406
Filing Date
2023-08-10
Accepted
2023-08-10 07:40:32
Documents
91
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20230630x10q.htm   iXBRL 10-Q 2238933
2 EX-31.1 aplt-20230630xex31d1.htm EX-31.1 13937
3 EX-31.2 aplt-20230630xex31d2.htm EX-31.2 13662
4 EX-32.1 aplt-20230630xex32d1.htm EX-32.1 6234
5 EX-32.2 aplt-20230630xex32d2.htm EX-32.2 6415
  Complete submission text file 0001558370-23-014406.txt   9450054

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20230630.xsd EX-101.SCH 73210
7 EX-101.CAL aplt-20230630_cal.xml EX-101.CAL 54152
8 EX-101.DEF aplt-20230630_def.xml EX-101.DEF 292368
9 EX-101.LAB aplt-20230630_lab.xml EX-101.LAB 542805
10 EX-101.PRE aplt-20230630_pre.xml EX-101.PRE 501648
85 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20230630x10q_htm.xml XML 1615719
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 231157214
SIC: 2834 Pharmaceutical Preparations